From genetics of inflammatory bowel disease towards mechanistic insights

Trends in Immunology

Volumn 34, Issue 8, 2013, Pages 371-378

  Graham, Daniel B ^a,b   Xavier, Ramnik J ^a,b  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Crohn's disease; Genome wide association study (GWAS); Genomics; Host defense; Inflammatory bowel disease (IBD); Mucosal immunity; Ulcerative colitis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTOME;

ANKYLOSING SPONDYLITIS; CROHN DISEASE; DISEASE PREDISPOSITION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENETICS; IMMUNOPHENOTYPING; MUCOSAL IMMUNITY; NONHUMAN; PATHOPHYSIOLOGY; PSORIASIS; REGULATORY RNA SEQUENCE; REVIEW; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

CROHN'S DISEASE; GENOME-WIDE ASSOCIATION STUDY (GWAS); GENOMICS; HOST DEFENSE; INFLAMMATORY BOWEL DISEASE (IBD); MUCOSAL IMMUNITY; ULCERATIVE COLITIS;

GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84881030701     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.04.001     Document Type: Review

References (95)

1. Jostins L., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
2. Strange A., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 2010, 42:985-990.
3. Ellinghaus E., et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat. Genet. 2010, 42:991-995.
4. Huffmeier U., et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat. Genet. 2010, 42:996-999.
5. Wang C., et al. The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90. Nat. Immunol. 2013, 14:72-81.
6. Butter F., et al. Proteome-wide analysis of disease-associated SNPs that show allele-specific transcription factor binding. PLoS Genet. 2012, 8:e1002982.
7. Guttman M., et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458:223-227.
8. Derrien T., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22:1775-1789.
9. Guttman M., et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011, 477:295-300.
10. Moran I., et al. Human beta cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 2012, 16:435-448.
11. Gomez J.A., et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-gamma locus. Cell 2013, 152:743-754.
12. Hasler R., et al. Microbial pattern recognition causes distinct functional micro-RNA signatures in primary human monocytes. PLoS ONE 2012, 7:e31151.
13. Zwiers A., et al. Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production. J. Immunol. 2012, 188:1573-1577.
14. de Jong V.M., et al. Post-transcriptional control of candidate risk genes for type 1 diabetes by rare genetic variants. Genes Immun. 2012, 14:58-61.
15. Ueda H., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
16. Gerold K.D., et al. The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function. Diabetes 2011, 60:1955-1963.
17. Knight J.C. Resolving the variable genome and epigenome in human disease. J. Intern. Med. 2012, 271:379-391.
18. Orozco L.D., et al. Unraveling inflammatory responses using systems genetics and gene-environment interactions in macrophages. Cell 2012, 151:658-670.
19. Barreiro L.B., et al. Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1204-1209.
20. Heinig M., et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 2010, 467:460-464.
21. Ernst J., et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473:43-49.
22. Maurano M.T., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
23. Rivas M.A., et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet. 2011, 43:1066-1073.
24. Muto A., et al. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. EMBO J. 2010, 29:4048-4061.
25. Christodoulou K., et al. Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut 2012, 10.1136/gutjnl-2011-301833.
26. Briere F., et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J. Clin. Invest. 1994, 94:97-104.
27. Labbe C., et al. MAST3: a novel IBD risk factor that modulates TLR4 signaling. Genes Immun. 2008, 9:602-612.
28. Labbe C., et al. Genome-wide expression profiling implicates a MAST3-regulated gene set in colonic mucosal inflammation of ulcerative colitis patients. Inflamm. Bowel Dis. 2012, 18:1072-1080.
29. Zuk O., et al. The mystery of missing heritability: genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1193-1198.
30. Howson J.M., et al. Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes. Diabetes 2012, 61:3012-3017.
31. Ng S.C., et al. Role of genetic and environmental factors in British twins with inflammatory bowel disease. Inflamm. Bowel Dis. 2012, 18:725-736.
32. Ivanov I.I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
33. Sonnenberg G.F., Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012, 37:601-610.
34. Bernink J.H., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 2013, 14:221-229.
35. Kiss E.A., et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334:1561-1565.
36. Sonnenberg G.F., et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012, 336:1321-1325.
37. Fukuda S., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
38. Sun J.C., et al. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.
39. Cooper M.A., et al. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1915-1919.
40. O'Leary J.G., et al. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 2006, 7:507-516.
41. Quintin J., et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 2012, 12:223-232.
42. Cadwell K., et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010, 141:1135-1145.
43. Lindner C., et al. Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine. J. Exp. Med. 2012, 209:365-377.
44. Becker C., et al. Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 2013, 144:283-293.
45. Rath E., Haller D. Unfolded protein responses in the intestinal epithelium: sensors for the microbial and metabolic environment. J. Clin. Gastroenterol. 2012, 46(Suppl.):S3-S5.
46. Chang J.S., et al. Endoplasmic reticulum stress response promotes cytotoxic phenotype of CD8alphabeta+ intraepithelial lymphocytes in a mouse model for Crohn's disease-like ileitis. J. Immunol. 2012, 189:1510-1520.
47. Tannahill G.M., et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 2013, 496:238-242.
48. Nguyen N.T., et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19961-19966.
49. Wu C., et al. Induction of pathogenic T17 cells by inducible salt-sensing kinase SGK1. Nature 2013, 10.1038/nature11984.
50. Reynolds J.M., et al. Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C. J. Immunol. 2012, 189:4226-4230.
51. Stark M.A., et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22:285-294.
52. Conway K.L., et al. p40phox expression regulates neutrophil recruitment and function during the resolution phase of intestinal inflammation. J. Immunol. 2012, 189:3631-3640.
53. Matute J.D., et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 2009, 114:3309-3315.
54. Muise A.M., et al. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 2012, 61:1028-1035.
55. Zigmond E., et al. Ly6C(hi) monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 2012, 37:1076-1090.
56. Tait Wojno E.D., Artis D. Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. Cell Host Microbe 2012, 12:445-457.
57. Bevins C.L., Salzman N.H. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 2011, 9:356-368.
58. Lipinski S., et al. RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:21426-21431.
59. Chiang C.Y., et al. Cofactors required for TLR7- and TLR9-dependent innate immune responses. Cell Host Microbe 2012, 11:306-318.
60. Abecasis G.R., et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012, 491:56-65.
61. MacArthur D.G., et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012, 335:823-828.
62. Hampe J., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 2007, 39:207-211.
63. Rioux J.D., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 2007, 39:596-604.
64. Kuballa P., et al. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS ONE 2008, 3:e3391.
65. Moscou M.J., Bogdanove A.J. A simple cipher governs DNA recognition by TAL effectors. Science 2009, 326:1501.
66. Sanjana N.E., et al. A transcription activator-like effector toolbox for genome engineering. Nat. Protoc. 2012, 7:171-192.
67. Hockemeyer D., et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 2011, 29:731-734.
68. Reyon D., et al. FLASH assembly of TALENs for high-throughput genome editing. Nat. Biotechnol. 2012, 30:460-465.
69. Bedell V.M., et al. In vivo genome editing using a high-efficiency TALEN system. Nature 2012, 491:114-118.
70. Garneau J.E., et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010, 468:67-71.
71. Cong L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
72. Mali P., et al. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
73. Hammer G.E., et al. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat. Immunol. 2011, 12:1184-1193.
74. Yamanishi H., et al. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells. J. Immunol. 2012, 188:2164-2172.
75. Virgin H.W., Todd J.A. Metagenomics and personalized medicine. Cell 2011, 147:44-56.
76. Garg G., et al. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. J. Immunol. 2012, 188:4644-4653.
77. Khor B., et al. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474:307-317.
78. Yang S.K., et al. Genome-wide association study of ulcerative colitis in Koreans suggests extensive overlapping of genetic susceptibility with Caucasians. Inflamm. Bowel Dis. 2013, 19:954-966.
79. Juyal G., et al. An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. PLoS ONE 2011, 6:e16565.
80. Garrison W.D., et al. Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. Gastroenterology 2006, 130:1207-1220.
81. Bloch D.B., et al. Decreased IL-10 production by EBV-transformed B cells from patients with VODI: implications for the pathogenesis of Crohn disease. J. Allergy Clin. Immunol. 2012, 129:1678-1680.
82. Hauser F., et al. Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease. Genes Immun. 2012, 13:321-327.
83. Rausch P., et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19030-19035.
84. Miyoshi J., et al. Ectopic expression of blood type antigens in inflamed mucosa with higher incidence of FUT2 secretor status in colonic Crohn's disease. J. Gastroenterol. 2011, 46:1056-1063.
85. Smyth D.J., et al. FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection. Diabetes 2011, 60:3081-3084.
86. Kato Y., et al. Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1. Pharm. Res. 2010, 27:832-840.
87. Saeki N., et al. Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes Chromosomes Cancer 2009, 48:261-271.
88. McGovern D.P., et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 2010, 42:332-337.
89. Khan S.Q., et al. Cloning, expression, and functional characterization of TL1A-Ig. J. Immunol. 2013, 190:1540-1550.
90. Moran C.J., et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm. Bowel Dis. 2013, 19:115-123.
91. Ghoreschi K., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010, 467:967-971.
92. Hara H., et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 2007, 8:619-629.
93. Homer C.R., et al. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 2010, 139:1630-1641. 1641.e1-2.
94. Cheung H., et al. Accessory protein-like is essential for IL-18-mediated signaling. J. Immunol. 2005, 174:5351-5357.
95. Rhee I., Veillette A. Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat. Immunol. 2012, 13:439-447.